跳至主要内容
临床试验/NCT03831048
NCT03831048已完成不适用

Clinical Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Heart For Resuscitation, Preservation and Assessment of Hearts From Donors After Circulatory Death (DCD Heart Trial)

TransMedics49 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2019年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
TransMedics
入组人数
180
试验地点
49
主要终点
Survival

研究概览

简要总结

To evaluate the effectiveness of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation.

详细描述

A prospective, randomized and concurrent controlled, non-inferiority pivotal trial in which subjects who receive a DCD donor heart transplant will be compared to subjects who receive a standard criteria donor heart transplant (Standard of Care 1 [SOC1] and Standard of Care 2 [SOC2] - from both randomized and concurrent control groups), adjusting for differences in risk factors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Survival

时间窗: 6 months

Patient survival 6 months post-transplant

次要结局

  • Utilization Rate(Within 24 hours post-transplant)

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (49)

Loading locations...

相似试验